Pontificia Universidad Catolica de Chile
238
33
36
120
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
3.8%
9 terminated/withdrawn out of 238 trials
93.0%
+6.5% vs industry average
19%
45 trials in Phase 3/4
4%
5 of 120 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (238)
Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain
Role: lead
Feasibility of an Augmented Reality Novel Approach for the Rehabilitation of Chronic Low Back Pain Patients With Kinesiophobia
Role: lead
Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT
Role: collaborator
Impact of Immersive Virtual Reality (IVR) on Respiratory Effort: A Pilot Study in Healthy Adults
Role: lead
AI-Assisted Analgesia Copilot System
Role: lead
Impact of PEEP on Respiratory Effort During Assisted Ventilation
Role: lead
Efficacy of PIMUN by Reducing Intermittent Hypoxia Events
Role: lead
Augmented Reality Training for Simulated Vaginal Birth
Role: lead
Modular Intervention for Depression Study
Role: lead
Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis
Role: lead
Incidence and Risk Factors of Postoperative Chronic Pain in Patients Who Have Undergone Hallux Valgus Surgery
Role: lead
Effect of Dexamethasone on Plasma Levels of Bupivacaine and Dexamethasone After a Single-injection Interscalene Nerve Block.
Role: lead
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
Role: lead
Effectiveness of Retrolaminar Block in Lumbar Spine Fusion With Multimodal Analgesia
Role: lead
Metabolic Effects of Linoleic Acid-Rich Oil Compared to a Blend Oil in Adults With Insulin Resistance
Role: lead
Chronic Pain in the General Population of Chile
Role: lead
Validation of the Spanish Version of the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) in Chile
Role: lead
CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS
Role: lead
Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS
Role: lead
Electroencephalographic Biomarker to Predict Postoperative Delirium
Role: collaborator